Daniel Barber, President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 8,257 shares at $4.29 ($35K) on 2026-05-15, disclosed to the SEC on 2026-05-18.
Open-market sale of $35k AQST by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AQST | SELL | 2026-07-17 | $100K | — | Filing → |
| AQST | SELL | 2026-06-16 | $104K | — | Filing → |
| AQST | SELL | 2026-03-11 | $1.5M | — | Filing → |